N1 Life

N1 Life is a private, preclinical-stage biotech leveraging a proprietary AI-powered peptide platform, Absotride™, to overcome biological barriers for enhanced drug delivery. Founded by a Stanford professor and an entrepreneurial scientist, the company targets the skincare and dermatology markets with a focus on improving the penetration and efficacy of active ingredients. Operating as a platform technology company, N1 Life collaborates with partners to develop next-generation formulations, positioning itself at the intersection of biotech innovation and consumer skincare.

Absotride™: AI-powered synthetic peptide-based platform designed to enhance skin penetration, solubility, and targeted delivery of active ingredients for skincare and therapeutics.

N1 Life competes in the crowded transdermal drug delivery and cosmetic active enhancement space. Competitors range from large chemical and pharmaceutical companies with penetration enhancer portfolios to other biotech startups leveraging lipids, nanoparticles, or other peptide technologies. Differentiation hinges on the proven performance, safety, and formulation flexibility of the Absotride™ peptides.